Anzeige
Mehr »
Donnerstag, 15.05.2025 - Börsentäglich über 12.000 News
Verpasst du gerade die Buffett-Aktie der neuen Generation?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2JD8X | ISIN: US92243A2006 | Ticker-Symbol: NB11
Tradegate
14.05.25 | 19:36
0,358 Euro
-1,81 % -0,007
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
VAXART INC Chart 1 Jahr
5-Tage-Chart
VAXART INC 5-Tage-Chart
RealtimeGeldBriefZeit
0,3590,38709:53
0,3590,38709:47

Aktuelle News zur VAXART Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiVaxart signals cash runway into Q1 2026 while advancing COVID-19 and norovirus vaccine programs3
DiVaxart ernennt Jeroen Grasman zum neuen CFO1
DiVaxart appoints Jeroen Grasman as chief financial officer4
DiVaxart GAAP EPS of -$0.07 in-line, revenue of $20.9M1
VAXART Aktie jetzt für 0€ handeln
DiVaxart appoints Jeroen Grasman as new CFO2
DiVaxart, Inc. - 10-Q, Quarterly Report3
DiVaxart, Inc.: Vaxart Appoints Jeroen Grasman as Chief Financial Officer37- Mr. Grasman brings over two decades of biotech financial leadership experience - SOUTH SAN FRANCISCO, Calif., May 13, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) today announced the appointment...
► Artikel lesen
MoInsights Ahead: Vaxart's Quarterly Earnings3
MoVaxart, Inc. - 8-K, Current Report1
MoVaxart, Inc.: Vaxart Addresses Frequently Asked Questions on Reverse Stock Split Proposal in Definitive Proxy Statement127Company Urges Stockholders to Vote FOR Reverse Stock Split Proposal at Upcoming Annual Meeting to Avoid Nasdaq Delisting SOUTH SAN FRANCISCO, Calif., May 12, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc....
► Artikel lesen
05.05.Vaxart, Inc. - 8-K, Current Report2
05.05.Vaxart, Inc.: Vaxart CEO Issues Letter to Stockholders Highlighting Company Progress163Urges Stockholders to Vote FOR Reverse Stock Split Proposal at Upcoming Annual Meeting as Recommended by Leading Independent Proxy Advisory Firms SOUTH SAN FRANCISCO, Calif., May 05, 2025 (GLOBE NEWSWIRE)...
► Artikel lesen
30.04.Vaxart completes enrollment for oral norovirus vaccine trial6
28.04.HHS lifts stop work order on Vaxart's COVID-19 trial, continues funding for the 10,000-participant study8
28.04.Vaxart, Inc. - 8-K, Current Report6
27.03.Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)278SOUTH SAN FRANCISCO, Calif., March 27, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) (the "Company" or "Vaxart") today announced that on March 24, 2025, the independent members of the Board...
► Artikel lesen
24.03.Vaxart, Inc. (NASDAQ:VXRT) Q4 2024 Earnings Call Transcript2
21.03.Vaxart, Inc. - 8-K, Current Report3
21.03.Vaxart lays off 10% of staff after HHS unexpectedly demands halt to COVID vaccine trial7
20.03.Vaxart, Inc.: Vaxart Provides Business Update and Reports Full Year 2024 Financial Results195Initiated Phase 1 clinical trial evaluating its second-generation oral norovirus vaccine constructs with topline data expected as early as mid-2025 Continues per protocol follow-up for the COVID-19...
► Artikel lesen
Seite:  Weiter >>
46 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,3,2